Imunon, Inc. CLSN
1.95 +1.95
Day range unavailable
52-week range unavailable
News
globenewswire.com Celsion Corporation Announces Company Name Change to Imunon, Inc. New name reflects the evolution of the Company's business focus and its commitment to immunotherapies and vaccines
globenewswire.com Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer 110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone
globenewswire.com Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief…
globenewswire.com Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment Conference LAWRENCEVILLE, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company today announced that Dr. Corinne Le Goff, President and Chief…
globenewswire.com Celsion Corporation Highlights Progress in its DNA-based Vaccine Program PLACCINE DNA-based Vaccine Demonstrates Robust Response in Murine Model
seekingalpha.com Celsion Corporation's (CLSN) CEO Corinne Le Goff on Q2 2022 Results - Earnings Call Transcript Celsion Corporation (NASDAQ:CLSN ) Q2 2022 Earnings Conference Call August 15, 2022 11:00 AM ET Company Participants Monique Kosse - IR, LifeSci Advisors Michael Tardugno - Executive Chairman Corinne…
globenewswire.com Celsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update DNA Mediated Immunotherapy and Next-Generation Vaccine Programs Supported with a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT
benzinga.com Earnings Scheduled For August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
globenewswire.com Celsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022 LAWRENCEVILLE, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,…
globenewswire.com Celsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced…
globenewswire.com Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer Michael H. Tardugno appointed Executive Chairman of the Board
globenewswire.com Celsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable Risk/Benefit
seekingalpha.com Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2022 Results - Earnings Call Transcript Celsion Corporation (NASDAQ:CLSN ) Q1 2022 Earnings Conference Call May 16, 2022 11:00 AM ET Company Participants Monique Kosse - Investor Relations Michael Tardugno - Chairman, Chief Executive…
globenewswire.com Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update DNA Mediated Immunotherapy and Next-Generation Vaccine Programs Supported with a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT
benzinga.com Earnings Scheduled For May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
globenewswire.com Celsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates PLACCINE DNA-based Vaccine in proof-of-concept non-Human Primate Studies
globenewswire.com Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022 LAWRENCEVILLE, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,…
globenewswire.com Celsion Corporation Highlighted its PLACCINE Vaccine Platform Technology During Oral Presentation at the World Vaccine Congress Proprietary, Formulated DNA Plasmid Vaccine Candidate Shows Neutralizing Activity Against 2 Strains of the COVID-19 Virus
globenewswire.com Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well received at 2022 AACR A nnual M eeti ng
globenewswire.com Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced it…
globenewswire.com Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced registered direct…
benzinga.com 53 Biggest Movers From Yesterday Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average…
benzinga.com Why Celsion Shares Are Pulling Back Today Celsion Corp (NASDAQ: CLSN) shares are trading lower Wednesday after the company announced a $7 million registered direct offering priced at-the-market under Nasdaq rules. What To Know: The offering…
benzinga.com Earnings Scheduled For March 31, 2022 Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning trading, 87 companies set new 52-week lows.
benzinga.com Earnings Scheduled For November 15, 2021 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter.- benzinga.com Earnings Scheduled For August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
benzinga.com Earnings Scheduled For May 14, 2021 Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its first quarter.- benzinga.com 88 Biggest Movers From Yesterday Gainers Solid Biosciences Inc. (NASDAQ: SLDB) shares surged 41.8% to close at $9.74 on above-average session volume.
benzinga.com 84 Biggest Movers From Yesterday Gainers- benzinga.com 60 Stocks Moving In Thursday's Mid-Day Session Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner,
- benzinga.com Earnings Scheduled For November 16, 2020 Companies Reporting Before The Bell • Anterix (NASDAQ:ATEX) is likely to report quarterly loss at $0.56 per share on revenue of $490.00 thousand. • Azul (NYSE:AZUL) is likely to report quarterly loss…
benzinga.com Stocks That Hit 52-Week Lows On Thursday Before 10 a.m. ET Thursday, 104 stocks made new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 129 companies set new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low was Wells Fargo (NYSE: WFC).
benzinga.com 65 Biggest Movers From Yesterday Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after surging around 22% on Friday.- benzinga.com Stocks That Hit 52-Week Highs On Tuesday On Tuesday, 118 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com Stocks That Hit 52-Week Lows On Friday
benzinga.com Stocks That Hit 52-Week Lows On Wednesday - benzinga.com Stocks That Hit 52-Week Lows On Monday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
- benzinga.com Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
- benzinga.com 33 Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com Earnings Scheduled For March 30, 2016
- benzinga.com Earnings Scheduled For March 18, 2013
- benzinga.com Data Monitoring Committee Unanimously Recommends Continuation of Celsion's Phase III ThermoDox® HEAT Study